Professor and Associate Dean of Research
Midwestern University
Disclosure(s): Abbvie: Advisor/Consultant; Basilea: Advisor/Consultant; Cidara: Advisor/Consultant; DoseMe: Advisor/Consultant; Entasis: Advisor/Consultant; F2G: Advisor/Consultant; GSK: Advisor/Consultant; Lykos: Advisor/Consultant; Roche: Advisor/Consultant; Third Pole Therapeutics: Advisor/Consultant; Xelia: Advisor/Consultant
Dr. Marc Scheetz attained a Doctorate of Pharmacy from Butler University, earned a Masters of Science in Clinical Investigation degree at Northwestern University, and completed his pharmacy practice residency and an infectious diseases fellowship at Northwestern Memorial Hospital. Dr. Scheetz is an Associate Dean of Research and Professor at Midwestern University College of Pharmacy and holds a joint appointment in the Department of Pharmacology, College of Graduate Studies. Dr. Scheetz is the Director of the Pharmacometric Center of Excellence at Midwestern University. He currently practices clinically as an infectious diseases pharmacist at Northwestern Memorial Hospital in downtown Chicago, IL.
Dr. Scheetz has authored over 215 original research manuscripts and review articles in the area of anti-infective pharmacokinetics and pharmacodynamics and currently serves as a reviewer for several infectious diseases, pharmacy, and medical journals. His primary research interest lies in the interface of the pharmacokinetic/pharmacodynamic interaction (i.e. between antimicrobials, pathogens, and hosts). He is particularly interested in assessing modifiable pharmacologic variables in the treatment of infectious diseases and identifying optimal exposures against the backdrop of toxicity. His group studies toxicology in the laboratory as well as through clinical data modeling. Dr. Scheetz is actively engaged in local and national leadership positions and formerly served as a member of the FDA Antimicrobial Drugs Advisory Committee.